NIH-funded research R01 grant

A brief behavioral treatment for chronic pelvic pain

Official title: A BRIEF, TRANSDIAGNOSTIC COGNITIVE BEHAVIORAL TREATMENT FOR UROLOGIC CHRONIC PELVIC PAIN SYNDROME (UCPPS): PROCESS, PREDICTIONS, OUTCOMES

Funded at State University of New York at Buffalo · NIH-11159501 · Data updated 2026-11-12

This project is testing a short behavioral therapy to help people manage chronic pelvic pain and related conditions like irritable bowel syndrome.

More Pelvic Pain research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionState University of New York at Buffalo
NIH-funded
Lab location1 site (Amherst, United States)
Project startSeptember 21, 2021
Project endJuly 31, 2027
Funding year2025
Award (this year)$607,569
NIH project number5R01DK128927-05
Project IDNIH-11159501 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals aged 18-70 years, of any gender or race, who experience urologic chronic pelvic pain syndrome (UCPPS).

Less likely to help

Patients whose pain is not related to UCPPS or who are not interested in a behavioral therapy approach may not find this treatment beneficial.

What this research studies

Many people experience chronic pelvic pain, which can be hard to understand and treat, often alongside other conditions like irritable bowel syndrome or fibromyalgia. This project explores a new, brief cognitive behavioral therapy (CBT) designed to help individuals learn skills for managing their symptoms. The therapy focuses on changing unhelpful thinking patterns that can make pain worse. We hope this approach will offer a more effective and accessible way to improve chronic pelvic pain and its common related issues.

Why it matters

Potential benefit: If successful, this brief behavioral treatment could offer a more efficient and accessible way for patients to find relief from chronic pelvic pain and its related conditions.

How similar studies have gone: Preliminary research has shown that a similar transdiagnostic behavioral treatment can reduce the severity of irritable bowel syndrome and other chronic overlapping pain conditions.

Where this research is happening

  • State University of New York at Buffalo
    Amherst, United States
    Active

Researchers

  • Principal investigator: Lackner, Jeffrey M — State University of New York at Buffalo
  • Study coordinator: Lackner, Jeffrey M

Related research

Other NIH-funded projects on the same topics.

  • Exploring allergy-based triggers to prevent UCPPS flare-ups

    A short, patient-friendly study will look at whether allergy-related antibodies can help predict and prevent flare-ups in people with urologic chronic pelvic pain syndrome.

    NIH research Washington University · Saint Louis, United States · NIH-11445166

  • Dual Cromolyn-Cetirizine oral capsule to help men with chronic pelvic pain

    A new oral medicine combining cromolyn sodium and cetirizine is being developed to help adults with chronic prostatitis/chronic pelvic pain by targeting immune and nerve-related pathways.

    NIH research Dolor Therapeutics, LLC · Chicago, United States · NIH-11407121

  • Chemical Clues in Chronic Pelvic Pain

    This project looks for unique chemical patterns in the body that could help us better understand and treat chronic pelvic pain in men and women.

    NIH research Washington University · Saint Louis, United States · NIH-11143622

  • Using glial cells to reduce visceral pain in bladder conditions

    This study is looking at how certain cells in the nervous system can be activated to help reduce the pain that comes with chronic pelvic pain syndrome, especially for those dealing with bladder issues, and it aims to find new treatment options that could eventually help people like you.

    NIH research University of Colorado Denver · Aurora, UNITED STATES · NIH-11140281

  • Improving treatment for chronic pelvic pain in men

    This study is looking to create a new oral medication to help men under 50 who suffer from chronic prostatitis/chronic pelvic pain syndrome, by combining two types of medicine that have shown promise, and it will first test these new formulas in dogs to find the best one before trying it in people.

    NIH research Dolor Therapeutics, LLC · Chicago, United States · NIH-10918611

  • Investigating the role of food-specific antibodies in chronic pelvic pain conditions.

    This study is looking at how certain foods might affect people with chronic pelvic pain, like interstitial cystitis and chronic prostatitis, to find out if changing what you eat can help ease your symptoms.

    NIH research Washington University · Saint Louis, United States · NIH-10914073

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.